ACTAVIS LABS FL INC FDA Approval ANDA 062521

ANDA 062521

ACTAVIS LABS FL INC

FDA Drug Application

Application #062521

Application Sponsors

ANDA 062521ACTAVIS LABS FL INC

Marketing Status

Discontinued001

Application Products

001SUSPENSION/DROPS;OTIC1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML0OTOCORTHYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE

CDER Filings

ACTAVIS LABS FL INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 62521
            [companyName] => ACTAVIS LABS FL INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"OTOCORT","activeIngredients":"HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE","strength":"1%;EQ 3.5MG BASE\/ML;10,000 UNITS\/ML","dosageForm":"SUSPENSION\/DROPS;OTIC","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"OTOCORT","submission":"HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE","actionType":"1%;EQ 3.5MG BASE\/ML;10,000 UNITS\/ML","submissionClassification":"SUSPENSION\/DROPS;OTIC","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.